These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Torchilin VP Adv Drug Deliv Rev; 2008 Mar; 60(4-5):548-58. PubMed ID: 18053612 [TBL] [Abstract][Full Text] [Related]
7. Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies. Haeri A; Osouli M; Bayat F; Alavi S; Dadashzadeh S Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1-14. PubMed ID: 29186990 [TBL] [Abstract][Full Text] [Related]
8. Perspectives on cutting-edge nanoparticulate drug delivery technologies based on lipids and their applications. Maddiboyina B; Ramaiah ; Nakkala RK; Roy H Chem Biol Drug Des; 2023 Aug; 102(2):377-394. PubMed ID: 36916008 [TBL] [Abstract][Full Text] [Related]
9. Receptor-targeted nanocarriers for therapeutic delivery to cancer. Yu B; Tai HC; Xue W; Lee LJ; Lee RJ Mol Membr Biol; 2010 Oct; 27(7):286-98. PubMed ID: 21028937 [TBL] [Abstract][Full Text] [Related]
10. Multifunctional polymeric micelles for delivery of drugs and siRNA. Jhaveri AM; Torchilin VP Front Pharmacol; 2014; 5():77. PubMed ID: 24795633 [TBL] [Abstract][Full Text] [Related]
12. Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers. Raza F; Zafar H; You X; Khan A; Wu J; Ge L J Mater Chem B; 2019 Dec; 7(48):7639-7655. PubMed ID: 31746934 [TBL] [Abstract][Full Text] [Related]
13. Passive and active drug targeting: drug delivery to tumors as an example. Torchilin VP Handb Exp Pharmacol; 2010; (197):3-53. PubMed ID: 20217525 [TBL] [Abstract][Full Text] [Related]
14. Stealth Nanocarriers in Cancer Therapy: a Comprehensive Review of Design, Functionality, and Clinical Applications. Saadh MJ; Mustafa MA; Kumar A; Alamir HTA; Kumar A; Khudair SA; Faisal A; Alubiady MHS; Jalal SS; Shafik SS; Ahmad I; Khry FAF; Abosaoda MK AAPS PharmSciTech; 2024 Jun; 25(6):140. PubMed ID: 38890191 [TBL] [Abstract][Full Text] [Related]
15. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Torchilin VP Nat Rev Drug Discov; 2014 Nov; 13(11):813-27. PubMed ID: 25287120 [TBL] [Abstract][Full Text] [Related]
16. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. Torchilin VP AAPS J; 2007 May; 9(2):E128-47. PubMed ID: 17614355 [TBL] [Abstract][Full Text] [Related]
18. Systemic Targeting of Lymph Node Metastasis through the Blood Vascular System by Using Size-Controlled Nanocarriers. Cabral H; Makino J; Matsumoto Y; Mi P; Wu H; Nomoto T; Toh K; Yamada N; Higuchi Y; Konishi S; Kano MR; Nishihara H; Miura Y; Nishiyama N; Kataoka K ACS Nano; 2015 May; 9(5):4957-67. PubMed ID: 25880444 [TBL] [Abstract][Full Text] [Related]
19. Raman microscopy for noninvasive imaging of pharmaceutical nanocarriers: intracellular distribution of cationic liposomes of different composition. Chernenko T; Sawant RR; Miljkovic M; Quintero L; Diem M; Torchilin V Mol Pharm; 2012 Apr; 9(4):930-6. PubMed ID: 22376068 [TBL] [Abstract][Full Text] [Related]
20. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles. Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]